Also from this source

You just read:

FDA Assigns PDUFA Date for Shire's FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema

News provided by

Shire plc

Mar 21, 2011, 07:00 ET